Our advisors


Expert advisors

The EHE Rare Cancer Charity (UK) will be dealing with different aspects of EHE in its daily operations including, as one of its core objectives, the periodic assessment of grant applications from research establishments and individuals.  Our Trustees will be advised on research and medical matters while performing their roles by our Research and Medical Advisory Team comprising Dr Brian Rubin from the Cleveland Clinic in Ohio, Dr Robin Jones from the Royal Marsden Hospital in London, and Dr Robin Young from the Weston Park Hospital in Sheffield. This team, experienced with EHE cancer, provides the charity with world-class cancer research and oncology expertise. This is essential to ensure, where relevant, that the correct analysis and decisions are made. In the case of research funding it will help ensure that we get the maximum benefit from every pound of research funds we award. The charity is extremely grateful to Dr Rubin, Dr Jones and Dr Young for the ongoing support, guidance and knowledge that they provide.


Dr Brian Rubin, MD, PhD is Professor of Pathology, Vice-Chair of Research within the Pathology Institute, and Director of Soft Tissue Pathology at the Cleveland Clinic. He received his PhD in molecular biology and his MD from Cornell University Medical College. He did his residency in Anatomic Pathology at Brigham and Women’s Hospital and received fellowship training in soft tissue pathology, bone pathology, and cancer genetics. Dr. Rubin has dedicated his career to a better understanding of the diagnosis and classification of soft tissue neoplasms, especially sarcomas, where he is a prominent figure nationally and internationally. He is widely regarded as a thought leader in the field and is a founding member of the International Society of Bone and Soft Tissue Pathology.



Dr Robin Jones is a medical oncologist, specialising in the treatment of bone and soft tissue sarcomas, and is Head of the Sarcoma Unit at the Royal Marsden Hospital in London. He has experience in conducting Phase I, II and III trials, as well translational studies in sarcoma. He trained in medical oncology at the Royal Marsden Hospital and between 2010 and 2014 he was Head of the Sarcoma Program at the University of Washington / Fred Hutchinson Cancer Research Center in Seattle. His main research interest focuses on clinical trials of novel agents and immunotherapy in sarcoma.




Dr Robin Young MBChB, MRCP, MSc, PhD is a consultant medical oncologist at Weston Park Hospital, Sheffield. He graduated from the University of Edinburgh in 1999. He moved to Sheffield in 2006 to undertake specialist medical oncology training, including three years as a Yorkshire Cancer Research clinical research fellow at the University of Sheffield. He was appointed a consultant medical oncologist at Weston Park Hospital in 2015. His clinical and research interests involve sarcoma and lung cancer. He is the principal investigator for Sheffield on a number of national and international clinical trials. His research interests focus on the role of the tumour microenvironment including the potential of vascular targeted therapy.